Literature DB >> 1381914

Bank vole monoclonal antibodies against Puumala virus envelope glycoproteins: identification of epitopes involved in neutralization.

A Lundkvist1, B Niklasson.   

Abstract

Bank vole (Clethrionomys glareolus) monoclonal antibodies (MAbs) against the two envelope glycoproteins (G 1 and G 2) of the Puumala (PUU) virus were generated and characterized. Analyses of the MAbs' antigen and epitope specificities showed non-overlapping reactivities of one anti-G 1 and two anti-G 2 MAbs. A significant neutralizing activity was shown by the anti-G 1 and one of the anti-G 2 MAbs, suggesting the existence of at least one neutralizing domain on each of the two glycoproteins. The two neutralizing MAbs reacted with eight PUU-related (serotype 3) virus strains, but did not react with Hantaan, Seoul, or Prospect Hill viruses in an immunofluorescence assay, indicating reactivity with epitopes unique for PUU virus. The non-neutralizing anti-G 2 MAb also reacted with Seoul virus, revealing the presence of a conserved G 2-epitope common for PUU and Seoul viruses, not involved in neutralization. Competitive binding of the MAbs and sera from nephropathia epidemica patients indicated that the defined neutralizing and non-neutralizing epitopes of the glycoproteins were immunodominant also in humans. In another experiment, magnetic beads coated with two MAbs were bound with the virus glycoproteins and used for selective enrichment of cells secreting anti-glycoprotein antibodies.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1381914     DOI: 10.1007/bf01309687

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  27 in total

1.  Characterization of glycoproteins of viruses causing hemorrhagic fever with renal syndrome (HFRS) using monoclonal antibodies.

Authors:  J R Dantas; Y Okuno; H Asada; M Tamura; M Takahashi; O Tanishita; Y Takahashi; T Kurata; K Yamanishi
Journal:  Virology       Date:  1986-06       Impact factor: 3.616

Review 2.  Molecular biology of the Bunyaviridae.

Authors:  R M Elliott
Journal:  J Gen Virol       Date:  1990-03       Impact factor: 3.891

3.  Isolation of the nephropathia epidemica agent in Sweden.

Authors:  B Niklasson; J Le Duc
Journal:  Lancet       Date:  1984-05-05       Impact factor: 79.321

4.  Hemorrhagic fever with renal syndrome in Finland: ecology and virology of nephropathia epidemica.

Authors:  M Brummer-Korvenkontio; H Henttonen; A Vaheri
Journal:  Scand J Infect Dis Suppl       Date:  1982

Review 5.  Korean hemorrhagic fever.

Authors:  H W Lee
Journal:  Prog Med Virol       Date:  1982

6.  Isolation in Vero-E6 cells of Hanta virus from Clethrionomys glareolus captured in the Bashkiria area of the U.S.S.R.

Authors:  E A Tkachenko; V N Bashkirtsev; G van der Groen; T K Dzagurova; A P Ivanov; E V Ryltseva
Journal:  Ann Soc Belg Med Trop       Date:  1984

7.  Monoclonal antibodies to three strains of hantaviruses: Hantaan, R22, and Puumala.

Authors:  S L Ruo; A Sanchez; L H Elliott; L S Brammer; J B McCormick; S P Fisher-Hoch
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

8.  Partial characterization of a Hantavirus isolated from a Clethrionomys glareolus captured in Belgium.

Authors:  G van der Groen; G Beelaert; G Hoofd; H Leirs; R Verhagen; H Yamanishi; E A Tkachenko; A P Ivanov
Journal:  Acta Virol       Date:  1987-03       Impact factor: 1.162

9.  Nephropathia epidemica: detection of antigen in bank voles and serologic diagnosis of human infection.

Authors:  M Brummer-Korvenkontio; A Vaheri; T Hovi; C H von Bonsdorff; J Vuorimies; T Manni; K Penttinen; N Oker-Blom; J Lähdevirta
Journal:  J Infect Dis       Date:  1980-02       Impact factor: 5.226

10.  Antigenic differences between two viruses, isolated in Japan and Korea, that cause hemorrhagic fever with renal syndrome.

Authors:  K Yamanishi; J R Dantas; M Takahashi; T Yamanouchi; K Domae; Y Takahashi; O Tanishita
Journal:  J Virol       Date:  1984-10       Impact factor: 5.103

View more
  41 in total

1.  Diagnostic potential of puumala virus nucleocapsid protein expressed in Drosophila melanogaster cells.

Authors:  K Brus Sjölander; I Golovljova; A Plyusnin; A Lundkvist
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Oligomerization of hantavirus nucleocapsid protein: analysis of the N-terminal coiled-coil domain.

Authors:  Agne Alminaite; Vera Halttunen; Vibhor Kumar; Antti Vaheri; Liisa Holm; Alexander Plyusnin
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

3.  A major antigenic domain of hantaviruses is located on the aminoproximal site of the viral nucleocapsid protein.

Authors:  P Gött; L Zöller; G Darai; E K Bautz
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

4.  Interactions and oligomerization of hantavirus glycoproteins.

Authors:  Jussi Hepojoki; Tomas Strandin; Antti Vaheri; Hilkka Lankinen
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

5.  Phage-displayed peptide targeting on the Puumala hantavirus neutralization site.

Authors:  T Heiskanen; A Lundkvist; A Vaheri; H Lankinen
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

6.  Recognition of decay accelerating factor and alpha(v)beta(3) by inactivated hantaviruses: Toward the development of high-throughput screening flow cytometry assays.

Authors:  Tione Buranda; Yang Wu; Dominique Perez; Stephen D Jett; Virginie BonduHawkins; Chunyan Ye; Bruce Edwards; Pamela Hall; Richard S Larson; Gabriel P Lopez; Larry A Sklar; Brian Hjelle
Journal:  Anal Biochem       Date:  2010-04-02       Impact factor: 3.365

7.  Phage display selection of cyclic peptides that inhibit Andes virus infection.

Authors:  Pamela R Hall; Brian Hjelle; Hadya Njus; Chunyan Ye; Virginie Bondu-Hawkins; David C Brown; Kathleen A Kilpatrick; Richard S Larson
Journal:  J Virol       Date:  2009-06-10       Impact factor: 5.103

8.  Antigenic characterization of Hantaan and Seoul virus nucleocapsid proteins expressed by recombinant baculovirus: application of a truncated protein, lacking an antigenic region common to the two viruses, as a serotyping antigen.

Authors:  M Morii; K Yoshimatsu; J Arikawa; G Zhou; H Kariwa; I Takashima
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

9.  Immunoglobulin G subclass responses against the structural components of Puumala virus.

Authors:  A Lundkvist; S Björsten; B Niklasson
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

10.  The humoral response to Puumala virus infection (nephropathia epidemica) investigated by viral protein specific immunoassays.

Authors:  A Lundkvist; J Hörling; B Niklasson
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.